Emilie Montastier1,2, Guillaume Becouarn3, Emilie Bérard4,5, Sophie Guyonnet6, Philippe Topart3, Patrick Ritz7,8. 1. UMR1048 INSERM, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases (I2MC), University of Toulouse III, Toulouse, France. 2. Department of Nutrition, Toulouse University Hospital, Toulouse, France. 3. Clinique de l'Anjou, Bariatric Surgery Department, Angers, France. 4. Department of Epidemiology, Health Economics and Public Health, Toulouse University Hospital, Toulouse, France. 5. UMR1027 INSERM-University of Toulouse III, Toulouse, France. 6. Gérontopôle, Toulouse University Hospital; UMR1027, INSERM-University of Toulouse III, Toulouse, France. 7. Department of Nutrition, Toulouse University Hospital, Toulouse, France. patrick.ritz@wanadoo.fr. 8. UMR1027 INSERM-University of Toulouse III, Toulouse, France. patrick.ritz@wanadoo.fr.
Abstract
BACKGROUND:Roux-en-Y gastric bypass (RYGB) has recently been authorized for use in older patients. The objective of this single-center study was to evaluate 2-year weight loss in patients ≥60 years compared with younger matched patients undergoing RYGB. Secondary aims were to record complications and the resolution of comorbidities in a 2-year follow-up. METHODS: Of 722 patients with at least 2 years follow-up data, 48 elderly patients were matched with 92 young (<40 years) and 96 middle-aged (40-59 year) patients, according to sex, baseline body mass index, and date of surgery. Weight loss, remission of comorbidities, death, and early (30-day) and 2-year complication rates were compared. RESULTS: There were three deaths in the elderly group and none in the other groups. The early complication rate was not significantly different in the elderly group (17.8 %) compared with the young (11.5 %, p = 0.637) and middle-aged (13.7 %, p = 1.000) groups. The 2-year complication rates were not significantly different in the elderly group (9.3 %) compared with the young (23.5 %, p = 0.107) and middle-aged (13.2 %, p = 1.000) groups. The 2-year weight loss was lower in the elderly group (31.8 ± 7.2 %; p < 0.001) than in the young group (38.3 ± 6.9 %) but was not significantly different from that in the middle-aged group (34.4 ± 8.0 %; p = 0.145). Remission rates for diabetes and obstructive sleep apnea were lower in the elderly than in the two younger groups. CONCLUSION: After bariatric surgery, major weight loss was observed in patients older than 60, but remission of metabolic comorbidities was less marked than in younger subjects.
RCT Entities:
BACKGROUND: Roux-en-Y gastric bypass (RYGB) has recently been authorized for use in older patients. The objective of this single-center study was to evaluate 2-year weight loss in patients ≥60 years compared with younger matched patients undergoing RYGB. Secondary aims were to record complications and the resolution of comorbidities in a 2-year follow-up. METHODS: Of 722 patients with at least 2 years follow-up data, 48 elderly patients were matched with 92 young (<40 years) and 96 middle-aged (40-59 year) patients, according to sex, baseline body mass index, and date of surgery. Weight loss, remission of comorbidities, death, and early (30-day) and 2-year complication rates were compared. RESULTS: There were three deaths in the elderly group and none in the other groups. The early complication rate was not significantly different in the elderly group (17.8 %) compared with the young (11.5 %, p = 0.637) and middle-aged (13.7 %, p = 1.000) groups. The 2-year complication rates were not significantly different in the elderly group (9.3 %) compared with the young (23.5 %, p = 0.107) and middle-aged (13.2 %, p = 1.000) groups. The 2-year weight loss was lower in the elderly group (31.8 ± 7.2 %; p < 0.001) than in the young group (38.3 ± 6.9 %) but was not significantly different from that in the middle-aged group (34.4 ± 8.0 %; p = 0.145). Remission rates for diabetes and obstructive sleep apnea were lower in the elderly than in the two younger groups. CONCLUSION: After bariatric surgery, major weight loss was observed in patients older than 60, but remission of metabolic comorbidities was less marked than in younger subjects.
Authors: Christopher M Willkomm; Tammy L Fisher; Gregory S Barnes; Colleen I Kennedy; Joseph A Kuhn Journal: Surg Obes Relat Dis Date: 2009-11-10 Impact factor: 4.734
Authors: Konstantinos Spaniolas; Thadeus L Trus; Gina L Adrales; Maureen T Quigley; Walter J Pories; William S Laycock Journal: Surg Obes Relat Dis Date: 2014-02-24 Impact factor: 4.734
Authors: S P Messier; C Legault; R F Loeser; S J Van Arsdale; C Davis; W H Ettinger; P DeVita Journal: Osteoarthritis Cartilage Date: 2010-12-04 Impact factor: 6.576
Authors: Stephanie E Dunkle-Blatter; Michael R St Jean; Carly Whitehead; William Strodel; Peter N Bennotti; Christopher Still; Mary Jane Reed; Craig G Wood; Anthony T Petrick Journal: Surg Obes Relat Dis Date: 2007-02-27 Impact factor: 4.734
Authors: John B Buse; Sonia Caprio; William T Cefalu; Antonio Ceriello; Stefano Del Prato; Silvio E Inzucchi; Sue McLaughlin; Gordon L Phillips; R Paul Robertson; Francesco Rubino; Richard Kahn; M Sue Kirkman Journal: Diabetes Care Date: 2009-11 Impact factor: 19.112
Authors: Stephen P Messier; Richard F Loeser; Gary D Miller; Timothy M Morgan; W Jack Rejeski; Mary Ann Sevick; Walter H Ettinger; Marco Pahor; Jeff D Williamson Journal: Arthritis Rheum Date: 2004-05
Authors: Hugo Meunier; Benjamin Menahem; Yannick Le Roux; Adrien Lee Bion; Yoann Marion; Antoine Vallois; Nicolas Contival; Thomas Gautier; Jean Lubrano; Anaïs Briant; Jean-Jacques Parienti; Arnaud Alves Journal: Obes Surg Date: 2021-04-28 Impact factor: 4.129
Authors: Paweł Marczuk; Michał J Kubisa; Michał Święch; Maciej Walędziak; Piotr Kowalewski; Piotr Major; Michał Pędziwiatr; Krzysztof Paśnik; Michał R Janik Journal: Obes Surg Date: 2019-02 Impact factor: 4.129